鶹ý

Filters close
鶹ý: PNNL Partners with DOE to Improve Access to DOE’s Intellectual Property
Released: 31-Jul-2024 7:30 AM EDT
PNNL Partners with DOE to Improve Access to DOE’s Intellectual Property
Pacific Northwest National Laboratory

Thousands of innovations created by the Department of Energy are more accessible in one place thanks to a new database created by DOE.

Released: 25-Jul-2024 2:05 AM EDT
XDive®: 5-Minute Real Time PCR Instrument with Expansion to a Superfast Sample-to-Answer Analyzer of Up to 256 Targets
ADLM 2024 Press Program

OnsiteGene Inc. launches XDive®, the first 5-minute real-time PCR instrument, achieving 40 thermal cycles with fluorescent imaging in 5 minutes. With FDA EUA for COVID-19, XDive offers efficiency, processing 16 samples and 64 targets per run. OnsiteGene seeks global distributors and collaborators.

鶹ý: Chulalongkorn Unveils “Microalbuminuria Rapid Test”: Easy, Accurate, Ready for Commercial Use
Released: 13-Jun-2024 8:55 AM EDT
Chulalongkorn Unveils “Microalbuminuria Rapid Test”: Easy, Accurate, Ready for Commercial Use
Chulalongkorn University

Ms. Supamas Isarabhakdi, Minister of Higher Education, Science, Research and Innovation, attended the launching of the innovative Microalbuminuria Rapid Test developed by a team of experts and researchers from the Faculty of Medicine, Chulalongkorn University. The test, which is convenient and easy to use and offers high accuracy, allows users to self-screen for kidney damage, giving it commercial potential in order to enhance Thailand’s healthcare system. It is expected for distribution in mid-2024.

Released: 12-Jun-2024 12:05 PM EDT
NIH collaborates with diagnostics manufacturers on obtaining authorization of multiplex tests
National Institute of Biomedical Imaging and Bioengineering

To date, nine medical device developers participating in the RADx® Tech Independent Test Assessment Program have received emergency use authorization for at-home and point-of care test products that simultaneously detect COVID-19 and flu A/B.

鶹ý: Ceevra Receives EU MDR Certification for its Surgical 3D Digital Imaging Platform
Released: 5-Jun-2024 12:30 PM EDT
Ceevra Receives EU MDR Certification for its Surgical 3D Digital Imaging Platform
Ceevra

Press release announcing Ceevra's certification under EU MDR.

鶹ý: Tube-eeze Patches Revolutionize Accessibility for Babies with Medical Equipment
Released: 19-Mar-2024 1:05 PM EDT
Tube-eeze Patches Revolutionize Accessibility for Babies with Medical Equipment
Tabeeze

Babies with medical devices such as g-tubes, j-tubes, PICC lines, ports, and more often face challenges in finding suitable clothing that accommodates their needs.

Released: 7-Mar-2024 10:05 AM EST
Parrish Medical Center Becomes a Cleveland Clinic Connected Member
Cleveland Clinic

CLEVELAND, OH and TITUSVILLE, FL: Cleveland Clinic and Parrish Medical Center, a Parrish Healthcare integrated care partner, jointly announced that Parrish Medical Center has become a member of Cleveland Clinic Connected.

   
鶹ý: Avails Medical Announces FDA Clearance of its eQUANT™ System to Accelerate Workflow for Antibiotic Susceptibility Testing
Released: 20-Feb-2024 7:55 AM EST
Avails Medical Announces FDA Clearance of its eQUANT™ System to Accelerate Workflow for Antibiotic Susceptibility Testing
Avails Medical, Inc.

Avails Medical, Inc., a leader in the development of rapid, automated and fully electrical antibiotic susceptibility testing (AST) technologies, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its groundbreaking eQUANTTM system.

Released: 13-Feb-2024 10:05 AM EST
Wasatch Biolabs Launches Proprietary Targeted DNA Methylation Sequencing Service for Researchers and Healthcare Providers
Wasatch BioLabs

Wasatch Biolabs (WBL), a subsidiary of Renew Biotechnologies and a certified Oxford Nanopore Technologies' laboratory, launches a proprietary Targeted DNA Methylation Sequencing Service for researchers and clinical service providers.

   
Released: 7-Feb-2024 9:05 AM EST
CSA Medical Announces 500th Metered CryoSpray Procedure for the Treatment of Chronic Bronchitis
CSA Medical

The RejuvenAir System is a minimally invasive medical device therapy which aims to target the underlying cause of COPD with Chronic Bronchitis.

Released: 6-Feb-2024 9:05 AM EST
Koning Health's Revolutionary Vera Breast CT Impresses at Arab Health in Dubai
Koning Corporation

Koning Health, a pioneer in advanced medical imaging technology, is proud to announce the successful showcasing of the Koning Vera Breast CT at the prestigious Arab Health exhibition in Dubai.

Released: 1-Feb-2024 2:05 PM EST
Stuart Therapeutics Announces Chief Medical and Chief Financial Officer Appointments
Stuart Therapeutics

Stuart Therapeutics, Inc. ("Stuart"), a clinical-stage biopharmaceutical company with candidate therapeutics in various phases of clinical development, today announced that it has appointed Jodi Luchs, MD to the position of Chief Medical Officer, and Don Stires to the position of Chief Financial Officer.

Released: 30-Jan-2024 11:05 AM EST
Harmonic Discovery Announces Licensing Agreement with BioVentures and UCSF for FLT3 Mutated AML Development Program
Harmonic Discovery

Harmonic Discovery (the "Company"), a precision pharmacology company focusing on developing next generation kinase inhibitors, today announced an exclusive licensing agreement of a novel small-molecule drug candidate for the treatment of FLT3 mutated acute myeloid leukemia (AML) from BioVentures (University of Arkansas for Medical Sciences) and UC San Francisco (UCSF).

Released: 24-Jan-2024 12:05 PM EST
FDA purchases digiM I2S software for the assessment of product quality attributes
digiM Solution

The U.S. Food and Drug Administration has placed a purchase order (75F40123P00369) committing to an annual subscription of digiM I2S, a fully integrated image processing platform based on digiM's proprietary cloud technology.

Released: 23-Jan-2024 2:05 PM EST
People with dementia or other forms of cognitive impairment smile, sing, and even dance with headphones on
Quiet Events Inc.

Quiet Events®, a leader in Silent Disco events and rentals, announces an exciting new partnership with the Day By Day Project, a pioneer in the innovative Memory Disco™ program.

Released: 12-Jan-2024 8:05 AM EST
Darmiyan Receives FDA Approval for BrainSee, the First Prognostic Test for Predicting Likelihood of Progression to Alzheimer's Dementia
Darmiyan

FDA's De Novo approval of BrainSee represents a major advancement in Alzheimer's diagnostics. Utilizing cutting-edge image processing and medical AI, BrainSee establishes a new standard for predicting progression from amnestic mild cognitive impairment (aMCI) to Alzheimer's dementia. This breakthrough is a significant step in proactive brain health management, offering a fully non-invasive, convenient, and globally accessible screening solution, to be prioritized before other tests or treatments.

Released: 11-Jan-2024 12:05 PM EST
Rockland Launches Impurity Detection Kit for Accurate Measurement of Nuclease Across a Spectrum of Therapeutic Manufacturing Methods
Rockland Immunochemicals, Inc

The AccuSignal™ Nuclease ELISA Kit is designed to detect any Serratia marcescens endonuclease, such as Benzonase®, DENARASE®, and Turbonuclease, to evaluate manufacturing processes for biological therapeutics, gene therapy vectors, vaccine preparations, and more.

Released: 8-Jan-2024 1:05 PM EST
Comprehensive Care Services Acquires Life Systems to Become Global Perfusion Leader
Comprehensive Care Services

omprehensive Care Services (CCS) has become the world's largest perfusion provider with the acquisition of German-based Life Systems. This move unites two leaders in perfusion care, expanding global access to top-tier patient services.

Released: 20-Dec-2023 1:05 PM EST
WRQ Sciences and Superfluid Dx., Inc. Announce Completion of Oversubscribed Series A Financing in Breakthrough Alzheimer's Disease Diagnostic Company Superfluid Dx
Superfluid Dx

WRQ Sciences and Superfluid Dx, Inc., announced today the completion of an oversubscribed Series A financing led by WRQ Sciences. With this transaction, WRQ Sciences has acquired majority ownership in the Alzheimer's Disease (AD) diagnostics company, Molecular Stethoscope, Inc., which is now renamed Superfluid Diagnostics, Inc. The Alzheimer's Drug Discovery Foundation's (ADDF) Diagnostics Accelerator (DxA) participated in the Series A financing.

Released: 5-Dec-2023 2:05 PM EST
Koning Health Showcases Groundbreaking Breast CT Technology at RSNA 2023
Koning Corporation

Koning Health, a leader in innovative breast imaging technology, is proud to announce its triumphant participation at the Radiological Society of North America (RSNA) 2023 Annual Meeting. The event, renowned for its educational courses, scientific sessions, and technical exhibits, provided an ideal platform for Koning to showcase its revolutionary product, the Koning Vera Breast CT.



close
0.14746